Maruyama M, Noda T, Kiyozuka Y, Oku M, Ninomiya Y, Ibaraki T, Katoh Y, Itani Y, Okamura Y, Beppu K
Dept. of Obstetrics & Gynecology, Nara Medical Univ.
Gan No Rinsho. 1988 May;34(6):815-9.
Reported in this paper is a case of a 56-year-old female patient who was diagnosed as having an ovarian cancer (stage T 4) with a renal dysfunction (CCr 30.5 ml/min). We instilled CDDP intra-peritoneally (CDDP-ip), taking into consideration the peritoneal clearance (CLp.). The administration of sodium thiosulphate also was combined. The low CLp. of this case (299.2 ml/h) made it possible to instill a high dose in the peritoneal cavity and a low dose in the plasma. This method provided enough of anti-tumor effect and kept the renal function safe. We believe that the CLp. is the most important factor in determining the effect and side effects of CDDp-ip.
本文报道了一例56岁女性患者,被诊断为患有卵巢癌(T4期)并伴有肾功能不全(肌酐清除率30.5 ml/min)。考虑到腹膜清除率(CLp),我们进行了顺铂腹腔内注射(CDDP-ip),同时联合使用硫代硫酸钠。该病例的低CLp(299.2 ml/h)使得能够在腹腔内注入高剂量而在血浆中注入低剂量。这种方法提供了足够的抗肿瘤效果并确保了肾功能安全。我们认为CLp是决定CDDp-ip疗效和副作用的最重要因素。